Skip to content

Carnitine status in fit and pre-frail/frail elderly compared to healthy young individuals

Carnitine status in fit and pre-frail/frail elderly compared to healthy young individuals - Fitaal

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43161
Enrollment
78
Registered
2016-08-23
Start date
2016-12-14
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

veroudering ageing increasing age

Interventions

None listed

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy young subjects (n

Exclusion criteria

Exclusion criteria: - Contra-indication for DEXA-scan, e.g. metal splinters - Contra-indication for muscle biopsy, e.g. use of anticoagulants. - a significant medical or surgical event or hospitalization within the previous three months - currently or the last three months treated by a medical specialist - diagnosed with cardiac failure, COPD or anaemia - diagnosed dementia and not having access to a daily caregiver and not able to make their own trade-off, which will be assessed at our discretion. The potential subjects have to be able to reproduce what is said; - diagnosed with cancer or receiving cancer treatment - not able to understand the Dutch language - Diagnosed neuromuscular disorders - taking carnitine supplements - current participation in other research - usage of the following medications: o Systemic corticosteroids o Fibrates o Valproic acid o Emetine o Zidovudine;Additional exclusion criteria for the young individuals: - Pregnant and nursing women - Diabetes Mellitus type I and II - Limited amount of performing sports, not more than 5 times a week

Design outcomes

Primary

MeasureTime frame
The primary study paramater is intramuscular carnitine levels and the intramuscular carnitine derivatives.

Secondary

MeasureTime frame
The secondary study parameters are: - carnitine status and its derivates in PBMCs - mitochondrial function in muscle tissue and PBMCs - Fat and fat-free mass - Plasma carnitine and its derivatives - Short Physical Performance Battery - 400m walk time - Cognitive function

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)